MiR-101 induces LSCC cells apoptosis via targeting CDK8, and is dramatically reduced in LSCC tissues and related to clinical stages, T stages, lymph node metastasis, and poor prognosis20. The gene discussed is CDK8; the disease is metastatic malignant neoplasm in the lymph nodes.